1. Home
  2. ATS vs IRON Comparison

ATS vs IRON Comparison

Compare ATS & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$26.51

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$75.22

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
IRON
Founded
1978
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
ATS
IRON
Price
$26.51
$75.22
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$35.00
$103.18
AVG Volume (30 Days)
107.1K
560.7K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.99
N/A
Revenue Next Year
$4.52
$283.52
P/E Ratio
$222.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.85
$40.00
52 Week High
$35.82
$99.50

Technical Indicators

Market Signals
Indicator
ATS
IRON
Relative Strength Index (RSI) 38.24 52.69
Support Level $23.85 $70.29
Resistance Level $28.99 $82.65
Average True Range (ATR) 0.78 3.26
MACD -0.04 -0.42
Stochastic Oscillator 22.66 32.98

Price Performance

Historical Comparison
ATS
IRON

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: